V3 Impact of the removal of treatment barriers on the microelimination of chronic hepatitis C in Slovak prisons: experience from real-life settings / Ivana Hockicková ... [et al.]. - DIGARCHUPJS. In: Clinical and Experimental Hepatology : official journal of the Polish Association for Study of Liver.. - ISSN 2392-1099. Roč. 11, č. 3 (2025), s. 271-278. 10.5114/ceh.2025.154078 DOI;DOI; WOS; [OV 180]; [ŠO 5141][HOCKICKOVÁ, Ivana ( Autor, 50% ) - HOCKICKO, Ján ( Autor, 5% ) - JARČUŠKA, Peter ( Autor, 10% ) - DRAŽILOVÁ, Sylvia ( Autor, 5% ) - LAMI, František DOK-51-I ( Autor, 5% ) - LENÁRTOVÁ, Denisa Patrícia ( Autor, 5% ) - MRÁŽIK, Pavol ( Autor, 5% ) - GÁBOR, Adrián ( Autor, 5% ) - KRISTIAN, Pavol ( Korešpondenčný autor, 10%)]

V3 Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies / Homie A. Razavi ...[et al.]. - DIGARCHUPJS. In: Journal of Hepatology. - ISSN 0168-8278. Roč. 83, č. 2 (2025), s. 329-347. 10.1016/j.jhep.2025.01.013 DOI;DOI; SCOPUS; [OV 180]; [ŠO 5141] [RAZAVI,, Homie ( Korešpondenčný autor, 0.67% ) - WAKED, Imam ( Autor, 0.645% ) - QURESHI, Huma ( Autor, 0.645% ) - KONDILI, Loreta A. ( Autor, 0.645% ) - DUBERG, Ann-Sofi ( Autor, 0.645% ) - DRAŽILOVÁ, Sylvia ( Autor, 0.645% ) - JANIČKO, Martin ( Autor, 0.645% ) - JARČUŠKA, Peter ( Autor, 0.645% ) - KRISTIAN, Pavol ( Autor, 0.645% ) - HOCKICKOVÁ, Ivana ( Autor, 0.645% ) - SCHRÉTER, Ivan ( Autor, 0.645%)]

V3 Distribution and relevance of hepatitis B genotypes in the general population of Slovakia [elektronický zdroj] / Ivana Hockicková ... [et al.]. In: Bratislava medical journal=Bratislavské lekárske listy. - ISSN 1336-0345. Roč. 125, č. 1 (2024), s. 17-23. - Spôsob prístupu: http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=8153&category_id=194&option=com_virtuemart&Itemid=1. Projekt: Význam nových biomarkerov hepatitídy B pre stratifikáciu rizika a manažment liečby pacientov s chronickou HBV infekciou - APVV APVV-18-0171. 10.4149/BLL_2024_004 DOI;DOI; SCOPUS; WOS; 2024 Nordic List=1; 2024 IF=1,1; 2024 AIS=0.279; 2024 CiteScore=2,8; 2024 SJR=0,458; 2024 SNIP=0,577; 2024 Q2(Medicine, general & internal) JCR; 2024 Q3(Medicine (miscellaneous)) Scimago; 2024 Q3(Medicine, general & internal) AIS; 2024 Q2(Medicine, general & internal) JCI [OV 180]; [ŠO 5141] [HOCKICKOVÁ, Ivana ( Autor, 55% ) - HATALOVÁ, Elena ( Korešpondenčný autor, 10% ) - GAZDA, Jakub DOK-51-I ( Autor, 5% ) - LENÁRTOVÁ, Patrícia Denisa DOK-51-I ( Autor, 10% ) - JANIČKO, Martin ( Autor, 5% ) - JARČUŠKA, Peter ( Autor, 2% ) - DRAŽILOVÁ, Sylvia ( Autor, 2% ) - LOGOIDA, Mariia ( Autor, 2% ) - HALÁNOVÁ, Monika ( Autor, 2% ) - SCHRÉTER, Ivan ( Autor, 2% ) - KRISTIAN, Pavol ( Autor, 5%)] 

V3 Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study [elektronický zdroj] / The Polaris Observatory Collaborators. In: The Lancet Gastroenterology and Hepatology. - ISSN 2468-1253. Roč. 8, č. 10 (2023), s. 879-907. - Spôsob prístupu: https://www.scopus.com/record/display.uri?eid=2-s2.0-85169786860&origin=resultslist. 10.1016/S2468-1253(23)00197-8 DOI;DOI; SCOPUS; CCC; WOS; 2023 AIS=11.226; 2023 IF=30.9; 2023 Q1(Gastroenterology & hepatology) JCR; 2023 Q1(Gastroenterology) Scimago; 2023 Q1(Hepatology) Scimago; 2023 Q1(Gastroenterology & hepatology) AIS; 2023 Q1(Gastroenterology & hepatology) JCI [OV 180]; [ŠO 5141] [RAZAVI-SHEARER, Devin ( Autor, 0.572% ) - GAMKRELIDZE, Ivane ( Autor, 0.371% ) - PAN, Calvin ( Autor, 0.371% ) - JIA, Jidong ( Autor, 0.371% ) - BERG, Thomas ( Autor, 0.371% ) - GRAY, Richard ( Autor, 0.371% ) - LIM, Young Suk ( Autor, 0.371% ) - CHEN, Chien Jen ( Autor, 0.371% ) - OCAMA, Ponsiano ( Autor, 0.371% ) - DESALEGN, Hailemichael ( Autor, 0.371% ) - ABBAS, Zaigham ( Autor, 0.371% ) - ABDALLAH, Ayat ( Autor, 0.371% ) - AGHEMO, Alessio ( Autor, 0.371% ) - AHMADBEKOVA, Sabohat ( Autor, 0.371% ) - AHN, Sang Hoon ( Autor, 0.371% ) - AHO, Inka ( Autor, 0.371% ) - AKARCA, Ulus ( Autor, 0.371% ) - AL MASRI, Nasser ( Autor, 0.371% ) - ALALWAN, Abduljaleel ( Autor, 0.371% ) - ALAVIAN, Seyed ( Autor, 0.371% ) - AL-BUSAFI, Said ( Autor, 0.371% ) - ALEMAN, Soo ( Autor, 0.371% ) - ALFALEH, Faleh ( Autor, 0.371% ) - ALGHAMDI, Abdullah ( Autor, 0.371% ) - AL-HAMOUDI, Waleed ( Autor, 0.371% ) - KRISTIAN, Pavol ( Člen korporácie, 0.371% ) - SCHRÉTER, Ivan ( Člen korporácie, 0.371% ) - HOCKICKOVÁ, Ivana ( Člen korporácie, 0.371% ) - JARČUŠKA, Peter ( Člen korporácie, 0.371% ) - DRAŽILOVÁ, Sylvia ( Člen korporácie, 0.371% ) - JANIČKO, Martin ( Člen korporácie, 0.371% )]

V3 Viral hepatitis in Roma communities: vulnerabilities and improving care access / Pavol Kristian ... [et al.]. - DIGARCHUPJS. In: The Lancet Gastroenterology and Hepatology. - ISSN 2468-1253. Roč. 11, č. 3 (2026), s. 179-181. SCOPUS; CCC; WOS; [OV 180]; [ŠO 5141] [KRISTIAN, Pavol ( Autor, 50% ) - HOCKICKOVÁ, Ivana ( Autor, 15% ) - HALÁNOVÁ, Monika ( Autor, 10% ) - DRAŽILOVÁ, Sylvia ( Autor, 5% ) - ZAHORNACKÝ, Ondrej ( Autor, 5% ) - JARČUŠKA, Peter ( Korešpondenčný autor, 15%)] 

ITMS2014+: 313011T651 - Bioaktívne látky pre podporu zdravia a prevenciu chronických ochorení (PROBIO-3)

PP-COVID-20/0034 - Prevalenčná štúdia kolektívnej imunity SARS-CoV-2 v populácii východného Slovenska